Effects of Different Early Intensive Therapies on Long-term β-cell Function
Status:
Enrolling by invitation
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate and evaluate the effects of different oral
antihyperglycaemic agents combined with short-term continuous subcutaneous insulin
infusion(CSII)(1.CSII alone; 2.metformin and pioglitazone combined with CSII; 3. sitagliptin
combined with CSII) on long-term glycemic control and β-cell function in newly diagnosed type
2 diabetic patients.